Neonatal Neurology 2 Stroke Hemorrhage PVL CHO NICU

  • Slides: 46
Download presentation
Neonatal Neurology 2: Stroke, Hemorrhage, PVL CHO NICU Lecture D Durand Revised 10/17/12

Neonatal Neurology 2: Stroke, Hemorrhage, PVL CHO NICU Lecture D Durand Revised 10/17/12

Stroke

Stroke

Arterial or Venous Stroke Causes 15% of Seizures • Ischemic infarct – Arterial occlusion

Arterial or Venous Stroke Causes 15% of Seizures • Ischemic infarct – Arterial occlusion (MCA) – Watershed injury – Venous outflow obstruction • Thromboembolism – Fetal placental circulation – Prothrombotic disorders – Cardiac disorders (R-L shunts) • Sagittal sinus thrombosis – Hypernatremia, dehydration

Ischemic Perinatal Stroke • Serious but under-recognized event – Occurring in 1/4000 live births

Ischemic Perinatal Stroke • Serious but under-recognized event – Occurring in 1/4000 live births • Definition: – Focal disruption of CBF secondary to arterial or cerebral venous thrombosis or embolization between 20 weeks of fetal life through the 28 th postnatal day – Confirmed by neuroimaging or neuropathology studies.

Ischemic Perinatal Stroke • 85% of IPS occurs in term gestation infants • Low

Ischemic Perinatal Stroke • 85% of IPS occurs in term gestation infants • Low mortality (3 -10%) • Low recurrence rates (3 -5%) • Etiology: – 83% of arterial strokes involve the MCA • • 2/3 involving the left MCA 10% bilateral MCA

Arterial or Venous Stroke • May have few overt signs of encephalopathy • Clues

Arterial or Venous Stroke • May have few overt signs of encephalopathy • Clues to diagnosis: – Focal, clonic seizures common – Often after 24 hrs – Commonly noted later as asymmetric strength, movement – Lesion contralateral to affected side – Cause of hemiplegic cerebral palsy • Upper extremity, face

Factors Associated with Ischemic Perinatal Stroke • Maternal: – Thrombotic hx, infertility • Current

Factors Associated with Ischemic Perinatal Stroke • Maternal: – Thrombotic hx, infertility • Current pregnancy: – – • First pregnancy, primiparity Twin-twin pregnancy, FMH Maternal hypertension/pre-eclampsia, chorioamnionitis, maternal fever, PROM oligohydramnios Peripartum: – Signs of fetal distress, intervention during delivery including emergent cesarean, birth trauma • Neonatal: – Male sex, LGA, IUGR – Polycythemia, hypoglycemia, meningitis, sepsis, DIC – Congenital heart defects, need for vascular cannulation, ECMO

Evaluation for Suspected Stroke • Consult Neurology • Request placental pathology to look for

Evaluation for Suspected Stroke • Consult Neurology • Request placental pathology to look for vasculo-placental pathology – • Chorio, thrombus, infarcted tissue Evaluation for seizures – Continuous a. EEG until video EEG is done • Head US ASAP to evaluate for ICH • MRI ASAP, when clinically stable – – MRI head, MRV and MRA Consider repeat MRI in 5 -7 days if CSVT

Evaluation for Suspected Stroke • Echocardiogram is not warranted unless there are cardiac signs

Evaluation for Suspected Stroke • Echocardiogram is not warranted unless there are cardiac signs or symptoms • If maternal hx of thrombotic events or multiple miscarriages, rec OB to test mom for antiphospholipid antibodies, lipoprotein (a), FVL • If maternal hx for possible drug use, obtain maternal and newborn tox screen

Evaluation for Suspected Stroke • Testing for thrombophilia in the acute setting of an

Evaluation for Suspected Stroke • Testing for thrombophilia in the acute setting of an isolated thrombotic stroke will not change management – Results are not reliable in the NB period – If heparin treatment is being considered, an ATIII level and full hypercoag panel should be checked prior to tx • If family hx of thrombophilia or thrombotic disorder – ATIII, ACA, lipoprotein (a), FVL • All patients should be referred to hematology outpatient clinic, to discuss implications of additional testing past the newborn period

Stroke Management • • Avoid dehydration Blood pressure/perfusion – – • Glucose – •

Stroke Management • • Avoid dehydration Blood pressure/perfusion – – • Glucose – • Maintain goal Sp. O 2 (89 -94%) Ventilation – • Avoid hyperthermia, aim 36 -37 degrees temp Oxygenation – • Maintain normal serum glucose Temperature – • Maintain cardiac output and normal BP Treat with volume/inotropes/pressors as needed Avoid hyperventilation Treat seizures with anticonvulsant – Phenobarbital, fosphenytoin, keppra

Stroke Management • • In most cases anticoagulation is not indicated Anticoagulation may be

Stroke Management • • In most cases anticoagulation is not indicated Anticoagulation may be considered with progressive ischemic infarction or: – – – • Relative contraindications for anticoagulation: – – – • • Clinical or radiological evidence of propagating CSVT despite supportive therapy Intracardiac or intravascular thrombus considered at risk for embolization Severe thrombophilic disorders Hemorrhagic transformation of the infarct MCA infarct >50% of territory Large cerebellar infarct Consult hematology if considering anticoagulation Check ATIII, coags, and d-dimers prior to starting heparin

Stroke Follow-Up • • Neurology at age 3 months Hematology within the first year

Stroke Follow-Up • • Neurology at age 3 months Hematology within the first year High Risk Infant Follow up Refer to local Regional Center or CCS MTU

Stroke Outcome • Remarkably good outcome in many infants with IPS – • Cortical

Stroke Outcome • Remarkably good outcome in many infants with IPS – • Cortical and subcortical plasticity and functional recovery Adverse outcome – – Hemiplegic CP (approx 30%) Visual Impairments (less than 1/3) • – – – • unusual in the absence of hemiplegia Cognitive deficits (approx 15 -25%) Behavioral problems (approx 10 -25%) Recurrence of seizure (approx 25 -50%) Predicting outcome – – If seizures, outcome seems to be worse Background normalization of EEG is good

Intracranial Hemorrhage

Intracranial Hemorrhage

Hemorrhage • “Outside” – Sub-galeal – above periosteum – Cephalohematoma – below periosteum •

Hemorrhage • “Outside” – Sub-galeal – above periosteum – Cephalohematoma – below periosteum • Extra-axial – Epidural – Sub-arachnoid • Germinal Matrix & Intraventricular – Grade 1 -4

“Peripheral” Hemorrhages

“Peripheral” Hemorrhages

Sub-Galeal Hemorrhage • Bleeding outside of periosteum • Not limited by ligaments at edges

Sub-Galeal Hemorrhage • Bleeding outside of periosteum • Not limited by ligaments at edges of bone

Cephalohematoma • Bleeding under periosteum • Limited by sutue ligaments

Cephalohematoma • Bleeding under periosteum • Limited by sutue ligaments

Periventricular-Intraventricular Hemorrhage • Complication of prematurity: – Incidence increases as gestational age decreases –

Periventricular-Intraventricular Hemorrhage • Complication of prematurity: – Incidence increases as gestational age decreases – 2 -3% in full term babies • Usually occurs in first week of life: – 50% occurs in 1 st 24 hrs of life – 90% occurs in 1 st week of life – Occasionally occurs in utero

Risk for IVH • Increases risk: – Low gestation – Rapid changes in BP

Risk for IVH • Increases risk: – Low gestation – Rapid changes in BP – Rapid changes in intra-thoracic pressure • Decreases risk: – Prenatal steroids – Indomethacin – Delayed cord clamping

Neuropathology: Subependymal Germinal Matrix • Site of glial cell proliferation • Richly vascularized •

Neuropathology: Subependymal Germinal Matrix • Site of glial cell proliferation • Richly vascularized • 26 -34 wks gestation • Involutes by 36 wks • Loose collection of vessels • Single endothelial layer • No connective tissue • Cerebral blood flow dysregulation • Passive pressure regulation

Neuropathology • Increased venous pressure (obstruction): – Head compression – Heart failure – Pneumothorax

Neuropathology • Increased venous pressure (obstruction): – Head compression – Heart failure – Pneumothorax • Increased arterial pressure: – Rapid volume expansion – Hypertension – Intubation – Suctioning

Intraventricular Hemorrhage • Pathophysiology – Rupture of SEH with extension into ventricle – Arachnoiditis

Intraventricular Hemorrhage • Pathophysiology – Rupture of SEH with extension into ventricle – Arachnoiditis and/or clot formation – Damage to surrounding glial precursor cells • 50% ventricular dilatation – 30% post hemorrhagic hydrocephalus – Communicating, slowly progressive – Non-communicating, rapid onset

Classification Grade I Isolated germinal matrix hemorrhage (GMH) AKA subependymal hemorrhage (SEH) Grade II

Classification Grade I Isolated germinal matrix hemorrhage (GMH) AKA subependymal hemorrhage (SEH) Grade II Intraventricular hemorrhage with normal sized ventricles (< 50% filled) Grade III Intraventricular hemorrhage with dilated ventricles (> 50% filled) Grade IV Intraventricular and parenchymal hemorrhage

Incidence • • Grade 1 Grade 2 Grade 3 Grade 4 11% 4% 7%

Incidence • • Grade 1 Grade 2 Grade 3 Grade 4 11% 4% 7% 5% from NICHD VLBW 18, 153 babies < 1500 gms

Hemorrhage and Long Term Neuro Outcome Grade I (GMH) 5% Grade II (IVH) 15%

Hemorrhage and Long Term Neuro Outcome Grade I (GMH) 5% Grade II (IVH) 15% Grade III (IVH with ventriculomegaly) 35% Grade IV (parenchymal hemorrhage) 90%

Normal Neonatal Brain Coronal View

Normal Neonatal Brain Coronal View

Normal Neonatal Brain Left Sagittal View

Normal Neonatal Brain Left Sagittal View

Grade I IVH

Grade I IVH

Gr II IVH

Gr II IVH

Grade III IVH

Grade III IVH

Grade IV IVH

Grade IV IVH

Grade IV IVH

Grade IV IVH

Periventricular Infarct Porencephalic Cyst

Periventricular Infarct Porencephalic Cyst

Post-Hemorrhagic Hydrocephalus

Post-Hemorrhagic Hydrocephalus

Post-Hemorrhagic Hydrocephalus • Occurs in 35% of babies with IVH • Communicating, slowly progressive

Post-Hemorrhagic Hydrocephalus • Occurs in 35% of babies with IVH • Communicating, slowly progressive – – Secondary to decreased CSF absorption by arachnoid villi Spontaneous resolution by 4 wks (65%) Slow progression for 1 st 4 wks, followed by arrest after 4 wks (20%) Progression after 4 wks (10%) • Non-communicating, rapidly evolving – Rapid progression during initial 4 wks (5%)

Rx of Post-Hemorrhagic Hydrocephalus • Medical Rx – not proven to be effective –

Rx of Post-Hemorrhagic Hydrocephalus • Medical Rx – not proven to be effective – Serial LPs – effective in old studies – Acetazolamide – not proven to be effective – Diuretics – not proven to be effective • Surgical Rx – Subcutaneous reservoir – External ventricular drain (rarely used) – VP shunt

Periventricular Leukomalacia

Periventricular Leukomalacia

Periventricular Leukomalacia • Cystic lesions in the periventricular white matter • 4% of VLBW

Periventricular Leukomalacia • Cystic lesions in the periventricular white matter • 4% of VLBW babies • Detected later in neonatal period • Probably related to: – Severe hypoxic, ischemic, or inflammatory events – in utero or neonatal • Risk factors: – – – Twins IUGR Cocaine Chorioamnionitis Hypocapnia!!!! (decreases CBF)

Periventricular Leukomalacia • Diffuse or focal • Bilateral and symmetric • Secondary hydrocephalus •

Periventricular Leukomalacia • Diffuse or focal • Bilateral and symmetric • Secondary hydrocephalus • Highest risk for later neurologic abnormalities

Periventricular leukomalacia

Periventricular leukomalacia

Periventricular Leukomalacia • Highest risk for cerebral palsy and spastic diplegia, quadriplegia, and visual

Periventricular Leukomalacia • Highest risk for cerebral palsy and spastic diplegia, quadriplegia, and visual deficit